• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     HAYES, Inc. EsophyX system with SerosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2012     Scottish Health Technologies Group (SHTG) What is the impact of using thresholds (both for referral and surgery) for first-eye cataract surgery on the delivery of the cataract service and the resources associated with it?
2012     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: accelerated repeat screening for bowel cancer
2012     NIHR Health Technology Assessment programme Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention in adults with mental health and substance use needs: a review of the clinical evidence and guidelines
2012     HAYES, Inc. Ex-PRESS glaucoma filtration device (Alcon Laboratories Inc.) for treatment of primary open-angle glaucoma
2012     Scottish Health Technologies Group (SHTG) The clinical and cost-effectiveness of radiofrequency ablation for lung cancer
2012     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: tuberculosis screening
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [A randomised controlled trial in the palliative setting regarding off-label medication: investigating the efficiency of amitriptyline versus pregabalin from a societal perspective]
2012     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization equipment and requirements for endoscopy equipment: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2012     HAYES, Inc. eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2012     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of temporal artery thermometers compared with infrared in-ear thermometers for temperature measurement in routine clinical practice?
2012     Health Council of the Netherlands Gezondheidsraad (GR) The National Immunisation Programme in the Dutch Caribbean
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Standard equipment for the usual care of bariatric patients: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Multigene panels in prostate cancer risk assessment
2012     HAYES, Inc. High-intensity focused ultrasound (HIFU) for treatment of hepatocellular carcinoma
2012     Health Council of the Netherlands Gezondheidsraad (GR) Health risks associated with livestock farms
2012     Adelaide Health Technology Assessment (AHTA) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework (stage II)
2012     NIHR Health Technology Assessment programme A methodological study to compare survey-based and observation-based evaluations of organisational and safety cultures and then compare both approaches with markers of the quality of care
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention strategies for substance misuse: a review of the clinical evidence
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - The patient-centered medical home
2012     HAYES, Inc. Intravenous lidocaine infusion for neuropathic pain
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [ACCURATE: Asthma Control Cost-Utility RAndomized Trial Evaluation Goals of asthma treatment: how high should we go?]
2012     HAYES, Inc. MelanoSITE™
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Mindfulness training for weight loss in obese adults: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Quality improvement interventions to address health disparities
2012     HAYES, Inc. MelaFind (MELA Sciences Inc.) for detection of malignant melanoma
2012     NIHR Health Technology Assessment programme The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy
2012     HAYES, Inc. Neuroblastoma RAS Viral Oncogene (NRAS) testing to predict treatment response in colorectal cancer
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for adult patients undergoing surgery: a review of clinical efficacy and safety
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Bundled payment: effects on health care spending and quality
2012     HAYES, Inc. METRx microscope system (Medtronic Sofamor Danek Inc.) for microdiscectomy for lumbar disc herniation
2012     NIHR Health Technology Assessment programme Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical oxygen treatment for wound healing: a review of clinical and cost-effectiveness
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Public reporting as a quality improvement strategy
2012     HAYES, Inc. Nerve integrity monitoring (NIM) systems (Medtronic Inc.) for intraoperative monitoring of motor nerve function during thyroidectomy
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of the demands and capacities model based treatment compared to the Lidcombe programme of early stuttering intervention: randomised trial]
2012     NIHR Health Technology Assessment programme Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Assessment of high sensitivity cardiac troponin T assay for the rapid diagnosis of acute coronary syndrome and acute myocardial infarction in the emergency room: a review of the clinical and economic evidence
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Medication adherence interventions: comparative effectiveness
2012     HAYES, Inc. O-arm imaging system (Medtronic Inc.) for guiding pedicle screw placement in thoracic and lumbosacral spinal surgery
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: an innovative strategy including a computerised decision support system compared to a common strategy of professional audit & feedback]
2012     HAYES, Inc. Transcription Factor 4 (TCF4) testing for Pitt-Hopkins Syndrome (PTHS)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Influenza vaccination for prevention of cross-species infection: a review of the clinical evidence
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Quality improvement measurement of outcomes for people with disabilities
2012     HAYES, Inc. Oasis wound matrix (Cook Biotech Inc.) for lower extremity ulcers
2012     NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis
2012     HAYES, Inc. VeriStrat® Test to predict response to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Removable rigid dressings for leg amputation: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Improving health care and palliative care for advanced and serious illness
2012     Agency for Healthcare Research and Quality (AHRQ) Long-term care for older adults: a review of home and community-based services versus institutional care
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Development and application of clinical prediction models in the presence of multilevel data]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Retreatment, switching and extended therapy with boceprevir and telaprevir for chronic hepatitis C infection: a review of the clinical effectiveness and safety
2012     Agency for Healthcare Research and Quality (AHRQ) Allocation of scarce resources during mass casualty events
2012     Agency for Healthcare Research and Quality (AHRQ) Biologic and nonbiologic systemic agents and phototherapy for treatment of chronic plaque psoriasis
2012     National Institute for Health and Care Excellence (NICE) New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners. NICE diagnostics guidance 3
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of anemia and neutropenia in patients with chronic hepatitis C infection treated with peginterferon-ribavirin based regimens with or without protease inhibitors: a review of the clinical evidence
2012     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of febrile infants (0–3 months)
2012     Agency for Healthcare Research and Quality (AHRQ) Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease
2012     NIHR Health Technology Assessment programme Systematic review of head cooling in adults after traumatic brain injury and stroke
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in special populations: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) An evidence review of active surveillance in men with localized prostate cancer
2012     Agency for Healthcare Research and Quality (AHRQ) Acute migraine treatment in emergency settings
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Enabling health care decisionmaking through clinical decision support and knowledge management
2012     Agency for Healthcare Research and Quality (AHRQ) Local hepatic therapies for metastases to the liver from unresectable colorectal cancer
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders]
2012     HTA Unit, University of Calgary Corneal crosslinking for keratoconus and corneal crosslinking for other corneal thinning disorders
2012     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial
2012     NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation interventions for pregnant women and mothers of infants: a review of the clinical effectiveness, safety, and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Evaluation and treatment of cryptorchidism
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Economic assessment of genetic test in breast cancer treatment]
2012     HTA Unit, University of Calgary Radiofrequency ablation for low back pain
2012     National Institute for Health and Care Excellence (NICE) Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy. NICE technology appraisal guidance 242
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Campus of care models for adults with disabilities and seniors: a review of clinical benefits and harms and cost-effectiveness
2012     Agency for Healthcare Research and Quality (AHRQ) Interventions to improve patient adherence to hepatitis C treatment: comparative effectiveness
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic Review of the efficacy, effectiveness, safety and cost of Preimplantational Genetic Screening]
2012     National Institute for Health and Care Excellence (NICE) Rituximab for the first-line treatment of stage III-IV follicular lymphoma. NICE technology appraisal guidance 243
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Lipid lowering agents for stroke prevention: a review of the clinical evidence, safety and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Prevention of healthcare associated infections
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Patient decision aids tool for colorectal cancer]
2012     National Institute for Health and Care Excellence (NICE) Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults. NICE technology appraisal guidance 245
2012     NIHR Health Technology Assessment programme Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran for stroke prevention in atrial fibrillation: a review of the evidence on safety
2012     NIHR Health Technology Assessment programme Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Identifying opportunities for health care disinvestment]
2012     Institute of Health Economics (IHE) The effectiveness and safety of preschool hearing screening programs
2012     National Institute for Health and Care Excellence (NICE) Pharmalgen for the treatment of bee and wasp venom allergy. NICE technology appraisal guidance 246
2012     HAYES, Inc. DaTscan (123I-Ioflupane; GE Healthcare) for diagnosis of Parkinson's Disease
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2012     NIHR Horizon Scanning Centre (NIHR HSC) Dacomitinib for advanced or metastatic non-small cell lung cancer – second or third line
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Safety and efficacy of the different techniques of left ventricular reconstructive surgery]
2012     Institute of Health Economics (IHE) The safety and effectiveness of preschool vision screening
2012     National Institute for Health and Care Excellence (NICE) Tocilizumab for the treatment of rheumatoid arthritis. NICE technology appraisal guidance 247
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of screening and treatment of high-risk fracture patients by an osteoporosis nurse-practitioner]
2012     NIHR Health Technology Assessment programme Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer
2012     HAYES, Inc. Diamondback 360° Orbital Atherectomy System (Cardiovascular Systems Inc.) for percutaneous atherectomy of lower-extremity peripheral arterial disease